Completed PHASE3 INTERVENTIONAL 2-arm NCT00986323

Efficacy Study of Temperature Controlled Laminar Airflow (TLA)-Treatment in Perennial Allergic Asthma (4A)

Airsonett Airshower in Allergic Asthma a Double-blind Randomized Multi-centre Trial

Sponsor: Airsonett AB

Conditions Asthma

Interventions Placebo TLA Temperature controlled Laminar Airflow (TLA)

Updated 7 times since 2017 Last updated: Nov 8, 2010 Started: Apr 30, 2008 Primary completion: Feb 28, 2010 Completion: Feb 28, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Asthma, this trial is completed. The trial is conducted by Airsonett AB and has accumulated 7 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Apr 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Airsonett AB
Commitum AB
Croel AB

Data source: Airsonett AB

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aarhus, Denmark , Bochum, Germany , Copenhagen, Denmark , Gothenburg, Sweden , Jönköping, Sweden , Karlstad, Sweden , Linköping, Sweden , London, United Kingdom , Lund, Sweden , München, Germany and 7 more locations